Heart Failure | Norton Healthcare

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Indication: Heart Failure

A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to
Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction

Sub-indication: Heart Failure

Study Type: Drug Study

Principal Investigator: Kelly McCants, M.D.
Norton Heart & Vascular Institute

Sponsor: Sponsor: Merck & Co., Inc

Learn more at ClinicalTrials.gov

Email for more information: cvresearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Heart Failure Clinical Trial

Schedule an Appointment